Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou, Jean–Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 215-229
Open Access | Times Cited: 436

Showing 1-25 of 436 citing articles:

Hepatocellular carcinoma
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4472
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Jeroen M. Bugter, Nicola Fenderico, Madelon M. Maurice
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 5-21
Closed Access | Times Cited: 348
Single‐cell RNA sequencing in cancer research
Yijie Zhang, Dan Wang, Peng Miao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 256
Hepatocellular carcinoma: old friends and new tricks
Eunsun Kim, Patrick Viatour
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 12, pp. 1898-1907
Open Access | Times Cited: 237
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
Yunhao Chen, Yanchun Zhao, Junru Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 221
Lipid alterations in chronic liver disease and liver cancer
Bichitra Paul, Monika Lewińska, Jesper B. Andersen
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 200
β-Catenin signaling in hepatocellular carcinoma
Chuanrui Xu, Zhong Xu, Yi Zhang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 173
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Yu Wang, Baocheng Deng
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 629-652
Closed Access | Times Cited: 167
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
Amit G. Singal, Yujin Hoshida, David J. Pinato, et al.
Gastroenterology (2021) Vol. 160, Iss. 7, pp. 2572-2584
Open Access | Times Cited: 125
Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response
Bufu Tang, Jinyu Zhu, Yajie Wang, et al.
Advanced Science (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 110
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 104
Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma
Hiroki Murai, Takahiro Kodama, Kazuki Maesaka, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 77-91
Open Access | Times Cited: 102
T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
Hao Chi, Songyun Zhao, Jinyan Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 99
Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives
Maxime Ronot, Victoria Chernyak, Adam M. Burgoyne, et al.
Radiology (2023) Vol. 307, Iss. 3
Closed Access | Times Cited: 54
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yun‐Fan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 135-156.e17
Closed Access | Times Cited: 51
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 33
HCC-Related lncRNAs: Roles and Mechanisms
Mimansha Shah, Devanand Sarkar
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 597-597
Open Access | Times Cited: 19
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis
Piyush Nathani, Purva Gopal, Nicole E. Rich, et al.
Gut (2020), pp. gutjnl-321040
Open Access | Times Cited: 117
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
Maite G. Fernández‐Barrena, María Arechederra, Leticia Colyn, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100167-100167
Open Access | Times Cited: 96
The changing scenario of hepatocellular carcinoma in Italy: an update
Francesca Garuti, Andrea Neri, Francesca Avanzato, et al.
Liver International (2020) Vol. 41, Iss. 3, pp. 585-597
Closed Access | Times Cited: 86
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
Michele Dal Bo, Elena De Mattia, Lorena Baboçi, et al.
Drug Resistance Updates (2020) Vol. 51, pp. 100702-100702
Open Access | Times Cited: 77
Deep learning‐based classification and mutation prediction from histopathological images of hepatocellular carcinoma
Haotian Liao, Yuxi Long, Ruijiang Han, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 2
Open Access | Times Cited: 76
Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 70
UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development
Renyu Zhang, Ze-Kun Liu, Wei Ding, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top